๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Interferon and interferon plus ribavirine in hepatocellular carcinoma prevention: A prospective study on patients with HCV related cirrhosis

โœ Scribed by Azzaroli, Francesco; Mazzella, Giuseppe; Accogli, Esterita; Giovanelli, Silvia; Trere', Davide; Mazzeo, Costanza; Nigro, Giovanni; Miracolo, Anna; Lodato, Francesca; Colecchia, Antonio; Mwangemi, Constance; Festi, Davide; Derenzini, Massimo; Roda, Enrico


Book ID
123166815
Publisher
Elsevier Science
Year
2003
Tongue
English
Weight
263 KB
Volume
124
Category
Article
ISSN
0016-5085

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Prevention of hepatocellular carcinoma r
โœ Vincenzo Mazzaferro; Raffaele Romito; Marcello Schiavo; Luigi Mariani; Tiziana C ๐Ÿ“‚ Article ๐Ÿ“… 2006 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 563 KB

Tumor recurrence after resection of hepatocellular carcinoma (HCC) can occur early (<2 years) or late (>2 years) as metastases or de novo tumors. Interferon (IFN) has the potential for chemoprevention against hepatitis C virus (HCV)-related cirrhosis. A predetermined group of 150 HCV RNA-positive pa